1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Paralysis Global Clinical Trials Review, H1, 2014

Paralysis Global Clinical Trials Review, H1, 2014

  • June 2014
  • -
  • Global Data
  • -
  • 76 pages

Paralysis Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Paralysis Global Clinical Trials Review, H1, 2014" provides data on the Paralysis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Paralysis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Paralysis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Paralysis Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Paralysis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Paralysis to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Paralysis to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Paralysis 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Paralysis Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Stemedica Cell Technologies, Inc. 32
Clinical Trial Overview of Stemedica Cell Technologies, Inc. 32
Teva Pharmaceutical Industries Limited 33
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 33
Teijin Limited 34
Clinical Trial Overview of Teijin Limited 34
ReNeuron Group plc 35
Clinical Trial Overview of ReNeuron Group plc 35
MacroGenics, Inc. 36
Clinical Trial Overview of MacroGenics, Inc. 36
Emergent BioSolutions Inc. 37
Clinical Trial Overview of Emergent BioSolutions Inc. 37
Bayer AG 38
Clinical Trial Overview of Bayer AG 38
Asahi Kasei Corporation 39
Clinical Trial Overview of Asahi Kasei Corporation 39
Clinical Trial Overview of Top Institutes / Government 40
National Institute of Neurological Disorders and Stroke 40
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 40
U.S. Department of Veterans Affairs 41
Clinical Trial Overview of U.S. Department of Veterans Affairs 41
Assistance Publique - Hopitaux de Paris 42
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 42
University of Miami 43
Clinical Trial Overview of University of Miami 43
University of Florida 44
Clinical Trial Overview of University of Florida 44
National Cancer Institute 45
Clinical Trial Overview of National Cancer Institute 45
Hadassah Medical Organization 46
Clinical Trial Overview of Hadassah Medical Organization 46
Medical University of Vienna 47
Clinical Trial Overview of Medical University of Vienna 47
Rouen University Hospital 48
Clinical Trial Overview of Rouen University Hospital 48
Imperial College London 49
Clinical Trial Overview of Imperial College London 49
Five Key Clinical Profiles 50
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76
Source 76

List of Tables
Paralysis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Paralysis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Paralysis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Paralysis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Paralysis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Paralysis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Paralysis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Paralysis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Paralysis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Paralysis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Paralysis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Paralysis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Paralysis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Paralysis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Paralysis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Paralysis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Paralysis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Paralysis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Paralysis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Paralysis Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Paralysis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Paralysis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Paralysis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Paralysis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Paralysis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Stemedica Cell Technologies, Inc., 2014* 32
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014* 33
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Teijin Limited, 2014* 34
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by ReNeuron Group plc, 2014* 35
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by MacroGenics, Inc., 2014* 36
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Emergent BioSolutions Inc., 2014* 37
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 38
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asahi Kasei Corporation, 2014* 39
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 40
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 41
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 42
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014* 43
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2014* 44
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 45
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 46
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 47
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2014* 48
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014* 49

List of Figures
Paralysis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Paralysis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Paralysis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Paralysis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Paralysis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Paralysis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Paralysis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Paralysis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Paralysis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Paralysis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Paralysis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Paralysis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Paralysis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Paralysis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Paralysis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Paralysis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Paralysis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Paralysis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Paralysis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Paralysis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Paralysis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Paralysis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Paralysis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 75

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.